Elsevier

The Lancet

Volume 359, Issue 9311, 23 March 2002, Pages 1037-1038
The Lancet

Research Letters
Fatal non-cardiogenic pulmonary oedema after intravenous nonionic radiographic contrast

https://doi.org/10.1016/S0140-6736(02)08068-6Get rights and content

Summary

Life-threatening reactions to radiographic contrast media are rare. We describe a case of fatal non-cardiogenic pulmonary oedema, after use of iopamidol, a widely used, low osmolar, non-ionic, radiographic contrast medium. A woman with a history of bladder tumour who had haematuria was referred for an intravenous urogram. After intravenous injection of 100 mL iopamidol, the woman became short of breath, and a chest radiograph showed severe pulmonary oedema. She was treated but subsequently died. The pathogenesis of contrastinduced, non-cardiogenic pulmonary oedema is unclear, and treatment differs from that for cardiogenic pulmonary oedema.

References (5)

There are more references available in the full text version of this article.

Cited by (24)

  • Late-onset acute respiratory distress syndrome induced by a gadolinium-based contrast agent: ARDS and gadolinium-based contrast agent

    2020, Respiratory Medicine Case Reports
    Citation Excerpt :

    Itchiness, rash, redness, and sneezing have also been observed [11,12]. The incidence of serious adverse events, such as dyspnea and anaphylactic hypotension, in this patient was low [1]; the incidences of adverse events after gadobutrol administration and anaphylaxis are 0.55% and 0.01%, respectively [13]. Anaphylactic reactions because of gadobutrol administration are characterized by their immediate onset; they occur in the first 5 min of administration in 82.7% cases and in the first 10 min of administration in 95.7% cases [14].

View all citing articles on Scopus
View full text